The exec has been at the helm of the company for 18 years.
{iframe}https://www.bizjournals.com/washington/news/2021/08/05/glycomimetics-ceo-rachel-king-steps-down.html{/iframe}
GlycoMimetics CEO Rachel King steps down, successor named – Washington Business Journal
The exec has been at the helm of the company for 18 years.
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.